1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with 2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chimenti, D; Chiozzi, P; Cuccato, S; Di Virgilio, F; Falzoni, S; Ferrannini, E; Lupi, R; Pratesi, F; Pugliese, G; Santini, E; Solini, A | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and 2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate
| Article | Year |
|---|---|
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Apoptosis; Calcium; Caspase 3; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Electrophysiology; Enzyme Activation; Extracellular Fluid; Flow Cytometry; Humans; Intracellular Membranes; Mesangial Cells; Microscopy, Phase-Contrast; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X4; Receptors, Purinergic P2X7; Time Factors | 2007 |